United States


A Takeda logo is seen in its research hub in Cambridge

Breakingviews - Takeda feeling uncomfortable Shire side effects

Takeda Pharmaceutical is showing signs of recovery after a mega-merger, but shareholders keep feeling the pain. Some 18 months after completing a $62 billion takeover of Irish rival Shire, the Japanese drugmaker may sell another business to further pare debt. Promised cost savings are also materialising. A weak stock performance, however, suggests Chief Executive Christophe Weber overpaid.

Business Video

Wells Fargo names new head of mortgage

Wells Fargo & Co said on Thursday it has hired Flagstar Bank's Kristy Fercho to run its mortgage division following the retirement of 23-year veteran Michael DeVito from the company.

HSBC and Nokia drag European stocks lower amid virus worries

HSBC and Nokia dragged European shares lower on Wednesday as a surge in coronavirus cases appeared to threaten a recovery in the global economy, while Britain's plan to head off an unemployment crisis cushioned a fall in London's domestically focused stocks.

Business News